Aβ immunotherapy drives immune activation and cerebrovascular damage in a mouse model of Alzheimer’s Disease
Xavier Taylor, Harun Noristani, Griffin Fitzgerald, Herold Oluoch, Nick Babb, Tyler McGathey, Justin T Hole, Pascale Lacor, Ronald B DeMattos, Yaming Wang, Neuroscience Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA · 2025
Read Aβ immunotherapy drives immune activation and cerebrovascular damage in a mouse model of Alzheimer’s Disease by Xavier Taylor, Harun Noristani, Griffin Fitzgerald, Herold Oluoch, Nick Babb, Tyler McGathey, Justin T Hole, Pascale Lacor, Ronald B DeMattos, Yaming Wang, Neuroscience Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710321.txt.
Description
Xavier Taylor and co-authors study side effects of amyloid therapy in a mouse model in a 2025 paper. Drugs that clear the amyloid protein in Alzheimer's disease can cause brain swelling and small bleeds, seen on scans as a known risk pattern. How the therapy sparks vessel damage has stayed unclear.
In mice prone to such bleeds, one antibody lit up vessel swelling and stripped muscle cells from vessel walls. The blood brain barrier lost its seal as a result. Profiling showed crowds of immune cells from the blood ringing the vessels. The team links activation of vessel side guard cells to the harm that follows.
Catalog record
| CREATOR | Xavier Taylor, Harun Noristani, Griffin Fitzgerald, Herold Oluoch, Nick Babb, Tyler McGathey, Justin T Hole, Pascale Lacor, Ronald B DeMattos, Yaming Wang, Neuroscience Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |